- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4168 - 1,3-Diazoles having a nitrogen atom attached in position 2, e.g. clonidine
Patent holdings for IPC class A61K 31/4168
Total number of patents in this class: 562
10-year publication summary
|
57
|
46
|
47
|
49
|
42
|
48
|
46
|
36
|
23
|
26
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Warsaw Orthopedic, Inc. | 3029 |
21 |
| Allergan, Inc. | 2350 |
18 |
| Rivus Pharmaceuticals, Inc. | 15 |
12 |
| Race Oncology Ltd. | 17 |
11 |
| The Regents of the University of California | 19887 |
10 |
| The Scripps Research Institute | 1348 |
8 |
| vTv Therapeutics LLC | 151 |
8 |
| Noven Pharmaceuticals, Inc. | 103 |
7 |
| Ligand Pharmaceuticals Incorporated | 169 |
6 |
| ThermoLife International, LLC | 126 |
6 |
| Theravet, société anonyme | 16 |
6 |
| Merck Sharp & Dohme LLC | 3749 |
6 |
| Bristol-myers Squibb Company | 4875 |
5 |
| Vireo Systems, Inc. | 67 |
5 |
| Jenivision, Inc. | 20 |
5 |
| Monopar Therapeutics Inc. | 22 |
5 |
| Glob-co SRL | 5 |
5 |
| AstraZeneca AB | 2923 |
4 |
| Alcon, Inc. | 5420 |
4 |
| Astex Therapeutics Limited | 237 |
4 |
| Other owners | 406 |